Global Radiopharmaceuticals in Nuclear Medical Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Radiopharmaceuticals in Nuclear Medical market size was valued at US$ million in 2023. With growing demand in downstream market, the Radiopharmaceuticals in Nuclear Medical is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Radiopharmaceuticals in Nuclear Medical market. Radiopharmaceuticals in Nuclear Medical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radiopharmaceuticals in Nuclear Medical. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radiopharmaceuticals in Nuclear Medical market.
Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Radiopharmaceuticals in Nuclear Medical market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radiopharmaceuticals in Nuclear Medical market. It may include historical data, market segmentation by Type (e.g., Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radiopharmaceuticals in Nuclear Medical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radiopharmaceuticals in Nuclear Medical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radiopharmaceuticals in Nuclear Medical industry. This include advancements in Radiopharmaceuticals in Nuclear Medical technology, Radiopharmaceuticals in Nuclear Medical new entrants, Radiopharmaceuticals in Nuclear Medical new investment, and other innovations that are shaping the future of Radiopharmaceuticals in Nuclear Medical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radiopharmaceuticals in Nuclear Medical market. It includes factors influencing customer ' purchasing decisions, preferences for Radiopharmaceuticals in Nuclear Medical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radiopharmaceuticals in Nuclear Medical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radiopharmaceuticals in Nuclear Medical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radiopharmaceuticals in Nuclear Medical market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radiopharmaceuticals in Nuclear Medical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radiopharmaceuticals in Nuclear Medical market.
Market Segmentation:
Radiopharmaceuticals in Nuclear Medical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Radiopharmaceuticals in Nuclear Medical market?
What factors are driving Radiopharmaceuticals in Nuclear Medical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceuticals in Nuclear Medical market opportunities vary by end market size?
How does Radiopharmaceuticals in Nuclear Medical break out type, application?
According to our LPI (LP Information) latest study, the global Radiopharmaceuticals in Nuclear Medical market size was valued at US$ million in 2023. With growing demand in downstream market, the Radiopharmaceuticals in Nuclear Medical is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Radiopharmaceuticals in Nuclear Medical market. Radiopharmaceuticals in Nuclear Medical are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Radiopharmaceuticals in Nuclear Medical. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Radiopharmaceuticals in Nuclear Medical market.
Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Radiopharmaceuticals in Nuclear Medical market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Radiopharmaceuticals in Nuclear Medical market. It may include historical data, market segmentation by Type (e.g., Diagnostic Radiopharmaceuticals, Therapy Radiopharmaceuticals), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Radiopharmaceuticals in Nuclear Medical market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Radiopharmaceuticals in Nuclear Medical market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Radiopharmaceuticals in Nuclear Medical industry. This include advancements in Radiopharmaceuticals in Nuclear Medical technology, Radiopharmaceuticals in Nuclear Medical new entrants, Radiopharmaceuticals in Nuclear Medical new investment, and other innovations that are shaping the future of Radiopharmaceuticals in Nuclear Medical.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Radiopharmaceuticals in Nuclear Medical market. It includes factors influencing customer ' purchasing decisions, preferences for Radiopharmaceuticals in Nuclear Medical product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Radiopharmaceuticals in Nuclear Medical market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Radiopharmaceuticals in Nuclear Medical market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Radiopharmaceuticals in Nuclear Medical market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Radiopharmaceuticals in Nuclear Medical industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Radiopharmaceuticals in Nuclear Medical market.
Market Segmentation:
Radiopharmaceuticals in Nuclear Medical market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Diagnostic Radiopharmaceuticals
- Therapy Radiopharmaceuticals
- Enriched Stable Isotopes
- Diagnostic Application
- Therapeutic Application
- Research
- Pharmaceutical
- Industrial
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco Imaging
- Cambridge Isotope Laboratories
- Cardinal Health
- Medtronic
- Eczacibasi-Monrol
- Fujifilm Holdings Corporation
- GE Healthcare (Subsidiary Of General Electric Company)
- IBA Group
- Lantheus Medical Imaging
- Nordion
- Ntp Radioisotopes
- Siemens Healthcare
- Taiyo Nippon Sanso Corporation
- Urenco Limited
- Rotem Industries
What is the 10-year outlook for the global Radiopharmaceuticals in Nuclear Medical market?
What factors are driving Radiopharmaceuticals in Nuclear Medical market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceuticals in Nuclear Medical market opportunities vary by end market size?
How does Radiopharmaceuticals in Nuclear Medical break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medical by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medical by Country/Region, 2019, 2023 & 2030
2.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapy Radiopharmaceuticals
2.2.3 Enriched Stable Isotopes
2.3 Radiopharmaceuticals in Nuclear Medical Sales by Type
2.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Type (2019-2024)
2.3.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Type (2019-2024)
2.4 Radiopharmaceuticals in Nuclear Medical Segment by Application
2.4.1 Diagnostic Application
2.4.2 Therapeutic Application
2.4.3 Research
2.4.4 Pharmaceutical
2.4.5 Industrial
2.5 Radiopharmaceuticals in Nuclear Medical Sales by Application
2.5.1 Global Radiopharmaceuticals in Nuclear Medical Sale Market Share by Application (2019-2024)
2.5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Application (2019-2024)
2.5.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Application (2019-2024)
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY COMPANY
3.1 Global Radiopharmaceuticals in Nuclear Medical Breakdown Data by Company
3.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Company (2019-2024)
3.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2019-2024)
3.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Company (2019-2024)
3.2.1 Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024)
3.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
3.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Product Location Distribution
3.4.2 Players Radiopharmaceuticals in Nuclear Medical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceuticals in Nuclear Medical Market Size by Geographic Region (2019-2024)
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Radiopharmaceuticals in Nuclear Medical Market Size by Country/Region (2019-2024)
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Country/Region (2019-2024)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Country/Region (2019-2024)
4.3 Americas Radiopharmaceuticals in Nuclear Medical Sales Growth
4.4 APAC Radiopharmaceuticals in Nuclear Medical Sales Growth
4.5 Europe Radiopharmaceuticals in Nuclear Medical Sales Growth
4.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceuticals in Nuclear Medical Sales by Country
5.1.1 Americas Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
5.1.2 Americas Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
5.2 Americas Radiopharmaceuticals in Nuclear Medical Sales by Type
5.3 Americas Radiopharmaceuticals in Nuclear Medical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals in Nuclear Medical Sales by Region
6.1.1 APAC Radiopharmaceuticals in Nuclear Medical Sales by Region (2019-2024)
6.1.2 APAC Radiopharmaceuticals in Nuclear Medical Revenue by Region (2019-2024)
6.2 APAC Radiopharmaceuticals in Nuclear Medical Sales by Type
6.3 APAC Radiopharmaceuticals in Nuclear Medical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceuticals in Nuclear Medical by Country
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
7.2 Europe Radiopharmaceuticals in Nuclear Medical Sales by Type
7.3 Europe Radiopharmaceuticals in Nuclear Medical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical by Country
8.1.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
8.1.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
8.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type
8.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical
10.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
10.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceuticals in Nuclear Medical Distributors
11.3 Radiopharmaceuticals in Nuclear Medical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Region
12.1.1 Global Radiopharmaceuticals in Nuclear Medical Forecast by Region (2025-2030)
12.1.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceuticals in Nuclear Medical Forecast by Type
12.7 Global Radiopharmaceuticals in Nuclear Medical Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Cambridge Isotope Laboratories
13.2.1 Cambridge Isotope Laboratories Company Information
13.2.2 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cambridge Isotope Laboratories Main Business Overview
13.2.5 Cambridge Isotope Laboratories Latest Developments
13.3 Cardinal Health
13.3.1 Cardinal Health Company Information
13.3.2 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cardinal Health Main Business Overview
13.3.5 Cardinal Health Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Eczacibasi-Monrol
13.5.1 Eczacibasi-Monrol Company Information
13.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Eczacibasi-Monrol Main Business Overview
13.5.5 Eczacibasi-Monrol Latest Developments
13.6 Fujifilm Holdings Corporation
13.6.1 Fujifilm Holdings Corporation Company Information
13.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Fujifilm Holdings Corporation Main Business Overview
13.6.5 Fujifilm Holdings Corporation Latest Developments
13.7 GE Healthcare (Subsidiary Of General Electric Company)
13.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Information
13.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GE Healthcare (Subsidiary Of General Electric Company) Main Business Overview
13.7.5 GE Healthcare (Subsidiary Of General Electric Company) Latest Developments
13.8 IBA Group
13.8.1 IBA Group Company Information
13.8.2 IBA Group Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 IBA Group Main Business Overview
13.8.5 IBA Group Latest Developments
13.9 Lantheus Medical Imaging
13.9.1 Lantheus Medical Imaging Company Information
13.9.2 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Lantheus Medical Imaging Main Business Overview
13.9.5 Lantheus Medical Imaging Latest Developments
13.10 Nordion
13.10.1 Nordion Company Information
13.10.2 Nordion Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nordion Main Business Overview
13.10.5 Nordion Latest Developments
13.11 Ntp Radioisotopes
13.11.1 Ntp Radioisotopes Company Information
13.11.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Ntp Radioisotopes Main Business Overview
13.11.5 Ntp Radioisotopes Latest Developments
13.12 Siemens Healthcare
13.12.1 Siemens Healthcare Company Information
13.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Siemens Healthcare Main Business Overview
13.12.5 Siemens Healthcare Latest Developments
13.13 Taiyo Nippon Sanso Corporation
13.13.1 Taiyo Nippon Sanso Corporation Company Information
13.13.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Taiyo Nippon Sanso Corporation Main Business Overview
13.13.5 Taiyo Nippon Sanso Corporation Latest Developments
13.14 Urenco Limited
13.14.1 Urenco Limited Company Information
13.14.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Urenco Limited Main Business Overview
13.14.5 Urenco Limited Latest Developments
13.15 Rotem Industries
13.15.1 Rotem Industries Company Information
13.15.2 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Rotem Industries Main Business Overview
13.15.5 Rotem Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medical by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Radiopharmaceuticals in Nuclear Medical by Country/Region, 2019, 2023 & 2030
2.2 Radiopharmaceuticals in Nuclear Medical Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapy Radiopharmaceuticals
2.2.3 Enriched Stable Isotopes
2.3 Radiopharmaceuticals in Nuclear Medical Sales by Type
2.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
2.3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Type (2019-2024)
2.3.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Type (2019-2024)
2.4 Radiopharmaceuticals in Nuclear Medical Segment by Application
2.4.1 Diagnostic Application
2.4.2 Therapeutic Application
2.4.3 Research
2.4.4 Pharmaceutical
2.4.5 Industrial
2.5 Radiopharmaceuticals in Nuclear Medical Sales by Application
2.5.1 Global Radiopharmaceuticals in Nuclear Medical Sale Market Share by Application (2019-2024)
2.5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Application (2019-2024)
2.5.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Application (2019-2024)
3 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY COMPANY
3.1 Global Radiopharmaceuticals in Nuclear Medical Breakdown Data by Company
3.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Company (2019-2024)
3.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2019-2024)
3.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Company (2019-2024)
3.2.1 Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024)
3.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
3.3 Global Radiopharmaceuticals in Nuclear Medical Sale Price by Company
3.4 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals in Nuclear Medical Product Location Distribution
3.4.2 Players Radiopharmaceuticals in Nuclear Medical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceuticals in Nuclear Medical Market Size by Geographic Region (2019-2024)
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Radiopharmaceuticals in Nuclear Medical Market Size by Country/Region (2019-2024)
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Annual Sales by Country/Region (2019-2024)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue by Country/Region (2019-2024)
4.3 Americas Radiopharmaceuticals in Nuclear Medical Sales Growth
4.4 APAC Radiopharmaceuticals in Nuclear Medical Sales Growth
4.5 Europe Radiopharmaceuticals in Nuclear Medical Sales Growth
4.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceuticals in Nuclear Medical Sales by Country
5.1.1 Americas Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
5.1.2 Americas Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
5.2 Americas Radiopharmaceuticals in Nuclear Medical Sales by Type
5.3 Americas Radiopharmaceuticals in Nuclear Medical Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals in Nuclear Medical Sales by Region
6.1.1 APAC Radiopharmaceuticals in Nuclear Medical Sales by Region (2019-2024)
6.1.2 APAC Radiopharmaceuticals in Nuclear Medical Revenue by Region (2019-2024)
6.2 APAC Radiopharmaceuticals in Nuclear Medical Sales by Type
6.3 APAC Radiopharmaceuticals in Nuclear Medical Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceuticals in Nuclear Medical by Country
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
7.2 Europe Radiopharmaceuticals in Nuclear Medical Sales by Type
7.3 Europe Radiopharmaceuticals in Nuclear Medical Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical by Country
8.1.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024)
8.1.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024)
8.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type
8.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical
10.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
10.4 Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceuticals in Nuclear Medical Distributors
11.3 Radiopharmaceuticals in Nuclear Medical Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICALS IN NUCLEAR MEDICAL BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Forecast by Region
12.1.1 Global Radiopharmaceuticals in Nuclear Medical Forecast by Region (2025-2030)
12.1.2 Global Radiopharmaceuticals in Nuclear Medical Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceuticals in Nuclear Medical Forecast by Type
12.7 Global Radiopharmaceuticals in Nuclear Medical Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Cambridge Isotope Laboratories
13.2.1 Cambridge Isotope Laboratories Company Information
13.2.2 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Cambridge Isotope Laboratories Main Business Overview
13.2.5 Cambridge Isotope Laboratories Latest Developments
13.3 Cardinal Health
13.3.1 Cardinal Health Company Information
13.3.2 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cardinal Health Main Business Overview
13.3.5 Cardinal Health Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Eczacibasi-Monrol
13.5.1 Eczacibasi-Monrol Company Information
13.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Eczacibasi-Monrol Main Business Overview
13.5.5 Eczacibasi-Monrol Latest Developments
13.6 Fujifilm Holdings Corporation
13.6.1 Fujifilm Holdings Corporation Company Information
13.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Fujifilm Holdings Corporation Main Business Overview
13.6.5 Fujifilm Holdings Corporation Latest Developments
13.7 GE Healthcare (Subsidiary Of General Electric Company)
13.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Information
13.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 GE Healthcare (Subsidiary Of General Electric Company) Main Business Overview
13.7.5 GE Healthcare (Subsidiary Of General Electric Company) Latest Developments
13.8 IBA Group
13.8.1 IBA Group Company Information
13.8.2 IBA Group Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 IBA Group Main Business Overview
13.8.5 IBA Group Latest Developments
13.9 Lantheus Medical Imaging
13.9.1 Lantheus Medical Imaging Company Information
13.9.2 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Lantheus Medical Imaging Main Business Overview
13.9.5 Lantheus Medical Imaging Latest Developments
13.10 Nordion
13.10.1 Nordion Company Information
13.10.2 Nordion Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Nordion Main Business Overview
13.10.5 Nordion Latest Developments
13.11 Ntp Radioisotopes
13.11.1 Ntp Radioisotopes Company Information
13.11.2 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Ntp Radioisotopes Main Business Overview
13.11.5 Ntp Radioisotopes Latest Developments
13.12 Siemens Healthcare
13.12.1 Siemens Healthcare Company Information
13.12.2 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Siemens Healthcare Main Business Overview
13.12.5 Siemens Healthcare Latest Developments
13.13 Taiyo Nippon Sanso Corporation
13.13.1 Taiyo Nippon Sanso Corporation Company Information
13.13.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Taiyo Nippon Sanso Corporation Main Business Overview
13.13.5 Taiyo Nippon Sanso Corporation Latest Developments
13.14 Urenco Limited
13.14.1 Urenco Limited Company Information
13.14.2 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Urenco Limited Main Business Overview
13.14.5 Urenco Limited Latest Developments
13.15 Rotem Industries
13.15.1 Rotem Industries Company Information
13.15.2 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
13.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Rotem Industries Main Business Overview
13.15.5 Rotem Industries Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceuticals in Nuclear Medical Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Radiopharmaceuticals in Nuclear Medical Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapy Radiopharmaceuticals
Table 5. Major Players of Enriched Stable Isotopes
Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 7. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2019-2024) & ($ million)
Table 9. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2019-2024)
Table 10. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Type (2019-2024) & (USD/MT)
Table 11. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 12. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2019-2024)
Table 14. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2019-2024)
Table 15. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Application (2019-2024) & (USD/MT)
Table 16. Global Radiopharmaceuticals in Nuclear Medical Sales by Company (2019-2024) & (K MT)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2019-2024)
Table 18. Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
Table 20. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Company (2019-2024) & (USD/MT)
Table 21. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Producing Area Distribution and Sales Area
Table 22. Players Radiopharmaceuticals in Nuclear Medical Products Offered
Table 23. Radiopharmaceuticals in Nuclear Medical Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Radiopharmaceuticals in Nuclear Medical Sales by Geographic Region (2019-2024) & (K MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Geographic Region (2019-2024)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales by Country/Region (2019-2024) & (K MT)
Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country/Region (2019-2024)
Table 32. Global Radiopharmaceuticals in Nuclear Medical Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 35. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 36. Americas Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 38. Americas Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 39. Americas Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 40. APAC Radiopharmaceuticals in Nuclear Medical Sales by Region (2019-2024) & (K MT)
Table 41. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2019-2024)
Table 42. APAC Radiopharmaceuticals in Nuclear Medical Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2019-2024)
Table 44. APAC Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 45. APAC Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 46. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 47. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 48. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 50. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 51. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 52. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 53. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 57. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals in Nuclear Medical
Table 59. Key Market Challenges & Risks of Radiopharmaceuticals in Nuclear Medical
Table 60. Key Industry Trends of Radiopharmaceuticals in Nuclear Medical
Table 61. Radiopharmaceuticals in Nuclear Medical Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 64. Radiopharmaceuticals in Nuclear Medical Customer List
Table 65. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2025-2030) & (K MT)
Table 66. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 68. Americas Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2025-2030) & (K MT)
Table 70. APAC Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 72. Europe Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 74. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2025-2030) & (K MT)
Table 76. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2025-2030) & (K MT)
Table 78. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Bracco Imaging Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 80. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 81. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Bracco Imaging Main Business
Table 83. Bracco Imaging Latest Developments
Table 84. Cambridge Isotope Laboratories Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 85. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 86. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Cambridge Isotope Laboratories Main Business
Table 88. Cambridge Isotope Laboratories Latest Developments
Table 89. Cardinal Health Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 90. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 91. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Cardinal Health Main Business
Table 93. Cardinal Health Latest Developments
Table 94. Medtronic Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 95. Medtronic Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 96. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Medtronic Main Business
Table 98. Medtronic Latest Developments
Table 99. Eczacibasi-Monrol Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 100. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 101. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Eczacibasi-Monrol Main Business
Table 103. Eczacibasi-Monrol Latest Developments
Table 104. Fujifilm Holdings Corporation Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 105. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 106. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Fujifilm Holdings Corporation Main Business
Table 108. Fujifilm Holdings Corporation Latest Developments
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 110. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 111. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. GE Healthcare (Subsidiary Of General Electric Company) Main Business
Table 113. GE Healthcare (Subsidiary Of General Electric Company) Latest Developments
Table 114. IBA Group Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 115. IBA Group Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 116. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. IBA Group Main Business
Table 118. IBA Group Latest Developments
Table 119. Lantheus Medical Imaging Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 120. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 121. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Lantheus Medical Imaging Main Business
Table 123. Lantheus Medical Imaging Latest Developments
Table 124. Nordion Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 125. Nordion Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 126. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Nordion Main Business
Table 128. Nordion Latest Developments
Table 129. Ntp Radioisotopes Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 130. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 131. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Ntp Radioisotopes Main Business
Table 133. Ntp Radioisotopes Latest Developments
Table 134. Siemens Healthcare Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 135. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 136. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Siemens Healthcare Main Business
Table 138. Siemens Healthcare Latest Developments
Table 139. Taiyo Nippon Sanso Corporation Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 140. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 141. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Taiyo Nippon Sanso Corporation Main Business
Table 143. Taiyo Nippon Sanso Corporation Latest Developments
Table 144. Urenco Limited Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 145. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 146. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Urenco Limited Main Business
Table 148. Urenco Limited Latest Developments
Table 149. Rotem Industries Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 150. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 151. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Rotem Industries Main Business
Table 153. Rotem Industries Latest Developments
Table 1. Radiopharmaceuticals in Nuclear Medical Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Radiopharmaceuticals in Nuclear Medical Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapy Radiopharmaceuticals
Table 5. Major Players of Enriched Stable Isotopes
Table 6. Global Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 7. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Table 8. Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2019-2024) & ($ million)
Table 9. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2019-2024)
Table 10. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Type (2019-2024) & (USD/MT)
Table 11. Global Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 12. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Table 13. Global Radiopharmaceuticals in Nuclear Medical Revenue by Application (2019-2024)
Table 14. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2019-2024)
Table 15. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Application (2019-2024) & (USD/MT)
Table 16. Global Radiopharmaceuticals in Nuclear Medical Sales by Company (2019-2024) & (K MT)
Table 17. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company (2019-2024)
Table 18. Global Radiopharmaceuticals in Nuclear Medical Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company (2019-2024)
Table 20. Global Radiopharmaceuticals in Nuclear Medical Sale Price by Company (2019-2024) & (USD/MT)
Table 21. Key Manufacturers Radiopharmaceuticals in Nuclear Medical Producing Area Distribution and Sales Area
Table 22. Players Radiopharmaceuticals in Nuclear Medical Products Offered
Table 23. Radiopharmaceuticals in Nuclear Medical Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Radiopharmaceuticals in Nuclear Medical Sales by Geographic Region (2019-2024) & (K MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Geographic Region (2019-2024)
Table 28. Global Radiopharmaceuticals in Nuclear Medical Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Radiopharmaceuticals in Nuclear Medical Sales by Country/Region (2019-2024) & (K MT)
Table 31. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country/Region (2019-2024)
Table 32. Global Radiopharmaceuticals in Nuclear Medical Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 35. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 36. Americas Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 38. Americas Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 39. Americas Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 40. APAC Radiopharmaceuticals in Nuclear Medical Sales by Region (2019-2024) & (K MT)
Table 41. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region (2019-2024)
Table 42. APAC Radiopharmaceuticals in Nuclear Medical Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Region (2019-2024)
Table 44. APAC Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 45. APAC Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 46. Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 47. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 48. Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 50. Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 51. Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 52. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2019-2024) & (K MT)
Table 53. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2019-2024) & (K MT)
Table 57. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2019-2024) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals in Nuclear Medical
Table 59. Key Market Challenges & Risks of Radiopharmaceuticals in Nuclear Medical
Table 60. Key Industry Trends of Radiopharmaceuticals in Nuclear Medical
Table 61. Radiopharmaceuticals in Nuclear Medical Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Radiopharmaceuticals in Nuclear Medical Distributors List
Table 64. Radiopharmaceuticals in Nuclear Medical Customer List
Table 65. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2025-2030) & (K MT)
Table 66. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 68. Americas Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Radiopharmaceuticals in Nuclear Medical Sales Forecast by Region (2025-2030) & (K MT)
Table 70. APAC Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 72. Europe Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Forecast by Country (2025-2030) & (K MT)
Table 74. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Type (2025-2030) & (K MT)
Table 76. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2025-2030) & (K MT)
Table 78. Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Bracco Imaging Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 80. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 81. Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Bracco Imaging Main Business
Table 83. Bracco Imaging Latest Developments
Table 84. Cambridge Isotope Laboratories Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 85. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 86. Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Cambridge Isotope Laboratories Main Business
Table 88. Cambridge Isotope Laboratories Latest Developments
Table 89. Cardinal Health Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 90. Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 91. Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Cardinal Health Main Business
Table 93. Cardinal Health Latest Developments
Table 94. Medtronic Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 95. Medtronic Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 96. Medtronic Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Medtronic Main Business
Table 98. Medtronic Latest Developments
Table 99. Eczacibasi-Monrol Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 100. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 101. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Eczacibasi-Monrol Main Business
Table 103. Eczacibasi-Monrol Latest Developments
Table 104. Fujifilm Holdings Corporation Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 105. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 106. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Fujifilm Holdings Corporation Main Business
Table 108. Fujifilm Holdings Corporation Latest Developments
Table 109. GE Healthcare (Subsidiary Of General Electric Company) Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 110. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 111. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. GE Healthcare (Subsidiary Of General Electric Company) Main Business
Table 113. GE Healthcare (Subsidiary Of General Electric Company) Latest Developments
Table 114. IBA Group Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 115. IBA Group Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 116. IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. IBA Group Main Business
Table 118. IBA Group Latest Developments
Table 119. Lantheus Medical Imaging Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 120. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 121. Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Lantheus Medical Imaging Main Business
Table 123. Lantheus Medical Imaging Latest Developments
Table 124. Nordion Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 125. Nordion Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 126. Nordion Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Nordion Main Business
Table 128. Nordion Latest Developments
Table 129. Ntp Radioisotopes Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 130. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 131. Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Ntp Radioisotopes Main Business
Table 133. Ntp Radioisotopes Latest Developments
Table 134. Siemens Healthcare Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 135. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 136. Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Siemens Healthcare Main Business
Table 138. Siemens Healthcare Latest Developments
Table 139. Taiyo Nippon Sanso Corporation Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 140. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 141. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Taiyo Nippon Sanso Corporation Main Business
Table 143. Taiyo Nippon Sanso Corporation Latest Developments
Table 144. Urenco Limited Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 145. Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 146. Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Urenco Limited Main Business
Table 148. Urenco Limited Latest Developments
Table 149. Rotem Industries Basic Information, Radiopharmaceuticals in Nuclear Medical Manufacturing Base, Sales Area and Its Competitors
Table 150. Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Portfolios and Specifications
Table 151. Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Rotem Industries Main Business
Table 153. Rotem Industries Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radiopharmaceuticals in Nuclear Medical
Figure 2. Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Radiopharmaceuticals in Nuclear Medical Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Diagnostic Radiopharmaceuticals
Figure 10. Product Picture of Therapy Radiopharmaceuticals
Figure 11. Product Picture of Enriched Stable Isotopes
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2023
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2019-2024)
Figure 14. Radiopharmaceuticals in Nuclear Medical Consumed in Diagnostic Application
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Market: Diagnostic Application (2019-2024) & (K MT)
Figure 16. Radiopharmaceuticals in Nuclear Medical Consumed in Therapeutic Application
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Market: Therapeutic Application (2019-2024) & (K MT)
Figure 18. Radiopharmaceuticals in Nuclear Medical Consumed in Research
Figure 19. Global Radiopharmaceuticals in Nuclear Medical Market: Research (2019-2024) & (K MT)
Figure 20. Radiopharmaceuticals in Nuclear Medical Consumed in Pharmaceutical
Figure 21. Global Radiopharmaceuticals in Nuclear Medical Market: Pharmaceutical (2019-2024) & (K MT)
Figure 22. Radiopharmaceuticals in Nuclear Medical Consumed in Industrial
Figure 23. Global Radiopharmaceuticals in Nuclear Medical Market: Industrial (2019-2024) & (K MT)
Figure 24. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2023)
Figure 25. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application in 2023
Figure 26. Radiopharmaceuticals in Nuclear Medical Sales Market by Company in 2023 (K MT)
Figure 27. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2023
Figure 28. Radiopharmaceuticals in Nuclear Medical Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company in 2023
Figure 30. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 33. Americas Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 34. APAC Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 35. APAC Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 37. Europe Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 39. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 40. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 41. Americas Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 42. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 43. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 44. United States Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region in 2023
Figure 49. APAC Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions in 2023
Figure 50. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 51. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 52. China Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 60. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 61. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 62. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 63. Germany Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 72. Egypt Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical in 2023
Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 79. Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
Figure 80. Channels of Distribution
Figure 81. Global Radiopharmaceuticals in Nuclear Medical Sales Market Forecast by Region (2025-2030)
Figure 82. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Radiopharmaceuticals in Nuclear Medical
Figure 2. Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Radiopharmaceuticals in Nuclear Medical Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Diagnostic Radiopharmaceuticals
Figure 10. Product Picture of Therapy Radiopharmaceuticals
Figure 11. Product Picture of Enriched Stable Isotopes
Figure 12. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type in 2023
Figure 13. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2019-2024)
Figure 14. Radiopharmaceuticals in Nuclear Medical Consumed in Diagnostic Application
Figure 15. Global Radiopharmaceuticals in Nuclear Medical Market: Diagnostic Application (2019-2024) & (K MT)
Figure 16. Radiopharmaceuticals in Nuclear Medical Consumed in Therapeutic Application
Figure 17. Global Radiopharmaceuticals in Nuclear Medical Market: Therapeutic Application (2019-2024) & (K MT)
Figure 18. Radiopharmaceuticals in Nuclear Medical Consumed in Research
Figure 19. Global Radiopharmaceuticals in Nuclear Medical Market: Research (2019-2024) & (K MT)
Figure 20. Radiopharmaceuticals in Nuclear Medical Consumed in Pharmaceutical
Figure 21. Global Radiopharmaceuticals in Nuclear Medical Market: Pharmaceutical (2019-2024) & (K MT)
Figure 22. Radiopharmaceuticals in Nuclear Medical Consumed in Industrial
Figure 23. Global Radiopharmaceuticals in Nuclear Medical Market: Industrial (2019-2024) & (K MT)
Figure 24. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2023)
Figure 25. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application in 2023
Figure 26. Radiopharmaceuticals in Nuclear Medical Sales Market by Company in 2023 (K MT)
Figure 27. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Company in 2023
Figure 28. Radiopharmaceuticals in Nuclear Medical Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Company in 2023
Figure 30. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 33. Americas Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 34. APAC Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 35. APAC Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 36. Europe Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 37. Europe Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales 2019-2024 (K MT)
Figure 39. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue 2019-2024 ($ Millions)
Figure 40. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 41. Americas Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 42. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 43. Americas Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 44. United States Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Region in 2023
Figure 49. APAC Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions in 2023
Figure 50. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 51. APAC Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 52. China Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 60. Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 61. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 62. Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 63. Germany Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2019-2024)
Figure 72. Egypt Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Radiopharmaceuticals in Nuclear Medical Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in Nuclear Medical in 2023
Figure 78. Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medical
Figure 79. Industry Chain Structure of Radiopharmaceuticals in Nuclear Medical
Figure 80. Channels of Distribution
Figure 81. Global Radiopharmaceuticals in Nuclear Medical Sales Market Forecast by Region (2025-2030)
Figure 82. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Application (2025-2030)
